211
Views
4
CrossRef citations to date
0
Altmetric
Psoriasis & Atopic Dermatitis

A randomised half body prospective study of low and medium dose regimens using the 308 nm excimer laser in the treatment of localised psoriasis

, , , , , & show all
Pages 8-13 | Received 16 Feb 2016, Accepted 28 Feb 2016, Published online: 29 Sep 2016

References

  • Nickoloff BJ, Nestle FO. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest. 2004;113:1664–75.
  • Weichenthal M, Schwarz T. Phototherapy: how does UV work? Photodermatol Photoimmunol Photomed. 2005;21:260–6.
  • Archier E, Devaux S, Castela E, et al. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 2012;26:22–31.
  • Kemeny L, Csoma Z, Bagdi E, et al. Targeted phototherapy of plaque-type psoriasis using ultraviolet B-light-emitting diodes. Br J Dermatol. 2010;163:167–73.
  • Waterston K, Naysmith L, Rees JL. Physiological variation in the erythemal response to ultraviolet radiation and photoadaptation. J Invest Dermatol. 2004;123:958–64.
  • Gupta G, Long J, Tillman DM. The efficacy of narrowband ultraviolet B phototherapy in psoriasis using objective and subjective outcome measures. Br J Dermatol. 1999;140:887–90.
  • Ibbotson SH, Bilsland D, Cox NH, et al. An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop Report. Br J Dermatol. 2004;151:283–97.
  • Ryan C, Renfro L, Collins P, et al. Clinical and genetic predictors of response to narrowband ultraviolet B for the treatment of chronic plaque psoriasis. Br J Dermatol. 2010;163:1056–63.
  • Bonis B, Kemeny L, Dobozy A, et al. 308 nm UVB excimer laser for psoriasis. Lancet. 1997;350:1522.
  • Trehan M, Taylor CR. Medium-dose 308-nm excimer laser for the treatment of psoriasis. J Am Acad Dermatol. 2002;47:701–8.
  • Tanghetti E, Gillis PR. Photometric and clinical assessment of localized UVB phototherapy systems for the high-dosage treatment of stable plaque psoriasis. J Cosmet Laser Ther. 2003;5:101–6.
  • Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol. 1981;76:359–62.
  • Palmer RA, Aquilina S, Milligan PJ, et al. Photoadaptation during narrowband ultraviolet-B therapy is independent of skin type: a study of 352 patients. J Invest Dermatol. 2006;126:1256–63.
  • Darne S, Stewart LC, Farr PM, Hampton PJ. Investigation of cutaneous photoadaptation to narrowband ultraviolet B. Br J Dermatol. 2014;170:392–7.
  • Asawanonda P, Anderson RR, Chang Y, Taylor CR. 308-Nm excimer laser for the treatment of psoriasis: a Dose-Response Study. Arch Dermatol. 2000;136:619–24.
  • Gerber W, Arheilger B, Ha TA, et al. Ultraviolet B 308-nm excimer laser treatment of psoriasis: a new phototherapeutic approach. Br J Dermatol. 2003;149:1250–8.
  • Feldman SR, Mellen BG, Housman TS, et al. Efficacy of the 308-nm excimer laser for treatment of psoriasis: results of a multicenter study. J Am Acad Dermatol. 2002;46:900–6.
  • Kollner K, Wimmershoff MB, Hintz C, et al. Comparison of the 308-nm excimer laser and a 308-nm excimer lamp with 311-nm narrowband ultraviolet B in the treatment of psoriasis. Br J Dermatol. 2005;152:750–4.
  • Kagen M, Cao LY, Oyetakin-White P, et al. Single administration of lesion-limited high-dose (TURBO) ultraviolet B using the excimer laser: clinical clearing in association with apoptosis of epidermal and dermal T-cell subsets in psoriasis. Photodermatol Photoimmunol Photomed. 2012;28:293–8.
  • Fischer T, Alsins J. Treatment of psoriasis with trioxsalen baths and dysprosium lamps. Acta Derm Venerol. 1976;56:383–90.
  • Bianchi B, Campolmi P, Mavilia L, et al. Monochromatic excimer light (308 nm): an immunohistochemical study of cutaneous T-cells and apoptosis-related molecules in psoriasis. J Eur Acad Dermatol Venereol. 2003;17:408–13.
  • Novak Z, Berces A, Ronto G, et al. Efficacy of different UV-emitting light sources in the induction of T-cell apoptosis. Photochem Photobiol. 2004;79:434–9.
  • Piskin G, Tursen U, Sylva-Steenland RM, et al. Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-gamma inducers – IL-12, IL-18 and IL-23. Exp Dermatol. 2004;13:764–72.
  • Ozawa M, Ferenczi K, Kikuchi T, et al. 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T-cells within psoriatic lesions. J Exp Med. 1999;189:711–18.
  • Young AR, Chadwick CA, Harrison GI, et al. The similarity of action spectra for thymine dimers in human epidermis and erythema suggests that DNA is the chromophore for erythema. J Invest Dermatol. 1998;111:982–8.
  • Gilchrest BA, Eller MS, Geller AC, Yaar M. The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med. 1999;340:1341–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.